EUCTR2015-005130-22-ES进行中（未招募）1 期
Randomised Controlled Trial with Pravastatin versus Placebo for Prevention of Pre-eclampsia STATIN - STATI
Fundación para la Formación e Investigación Sanitaria (FFIS)0 个研究点目标入组 2,000 人开始时间: 2016年7月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Age > 18 years;
- •Singleton pregnancies;
- •Live fetus at 11-13 weeks of gestation;
- •High-risk for preterm-PE at 11-13 weeks by the algorithm combining maternal history and characteristics, biophysical findings (mean arterial pressure and uterine artery Dopplers) and biochemical factors (placental growth factor);
- •Be fluent in the local language (otherwise interpreters will be used);
- •Informed and written consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2000
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Statin use in current pregnancy (administration must have ceased >28 days prior to randomisation);
- •Pregnancies complicated by major fetal abnormality identified at the 11-13 weeks’ assessment;
- •Women who are unconscious or severely ill, those with learning difficulties, or serious mental illness;
- •Women with contraindications for statin therapy:
- •Hypersensitivity to Pravastatin or any component of the product;
- •Active liver disease in the past 6 months (acute hepatitis, chronic active hepatitis, persistently abnormal liver enzymes (=two times higher than the upper limit of normal values for serum transaminases [ALT and/or AST], confirmed either by available blood results within the recruiting hospital within the last 6 months or blood taken prior to randomisation));
- •History of myopathy or rhabdomyolysis;
- •Women with any of the following conditions:
- •Status post solid organ transplant;
- •Chronic renal disease/insufficiency with baseline serum creatinine >1.5mg/dL;
- •Concurrent and chronic (>6 months) use of medications with potential drug interactions with statins, such as immunosuppressive drugs, fibrates, gemfibrozil, niacin, protease inhibitors, efavirenz (non-nucleoside reverse transcriptase inhibitor), erythromycin, clarithromycin, itraconazole, cholestyramine, digoxin, rifampicin (patients will not be excluded if the drug has been discontinued, or is prescribed for a short duration of time);
- •Participating in another intervention study that influences the outcomes of this study;
- •Plans to deliver in a non-network site,
- •Any other reason the clinical investigators think will prevent the potential participant from complying with the trial protocol.
研究者
相似试验
进行中（未招募）
1 期
Prevention of preeclampsia (high blood pressure): Randomised trial of Pravastatin versus placeboMedDRA version: 20.0Level: PTClassification code 10036485Term: Pre-eclampsiaSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsPre-eclampsiaEUCTR2016-005206-19-ESFundación para la Formación e Investigación Sanitaria (FFIS)1,120
进行中（未招募）
1 期
Prevention of preeclampsia (high blood pressure): Randomised trial of Pravastatin versus placeboPre-eclampsiaEUCTR2015-005130-22-GBFundación para la Formación e Investigación Sanitaria (FFIS)2,000
进行中（未招募）
1 期
Prevention of preeclampsia (high blood pressure): Randomised trial of Pravastatin versus placeboMedDRA version: 19.0Level: PTClassification code 10036485Term: Pre-eclampsiaSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsPre-eclampsiaEUCTR2015-005130-22-BEFundación para la Formación e Investigación Sanitaria (FFIS)2,000
进行中（未招募）
1 期
Prevention of preeclampsia (high blood pressure): Randomised trial of Pravastatin versus placeboMedDRA version: 20.0Level: PTClassification code 10036485Term: Pre-eclampsiaSystem Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsPre-eclampsiaEUCTR2016-005206-19-BEFundación para la Formación e Investigación Sanitaria (FFIS)1,120
进行中（未招募）
1 期
Prevention of preeclampsia (high blood pressure): Randomised trial of Pravastatin versus placeboMedDRA version: 20.0 Level: PT Classification code 10036485 Term: Pre-eclampsia System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditionsPre-eclampsiaEUCTR2016-005206-19-GBFundación para la Formación e Investigación Sanitaria (FFIS)1,120